Home / Recalls / Sentara Infusion Services / D-0295-2023

D-0295-2023 Class II Terminated

Recalled by Sentara Infusion Services — Chesapeake, VA

Recall Details

Product Type: Drugs
Report Date: February 22, 2023
Initiation Date: December 27, 2022
Termination Date: February 20, 2026
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 32 syringes

Product Description

HYDROCORTISONE 9a) 2MG IN NS 0.2ML SYRINGE, 9MG IN NS 2ML SYRINGE, steroid, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320, NDC# 00009-0011-04

Reason for Recall

Lack of sterility assurance

Distribution Pattern

Dispensed to Patients Nationwide.

Code Information

Beyond Use Date: December 24-31, 2022

Other recalls by Sentara Infusion Services

D-0319-2023 Class II — TPN 107gm/AA, 200gm/DEX, 50gm/LIP 2250mL, (b) 108GM/AA, 330GM/DEX 3000ML, (c) 10 (December 27, 2022)
D-0316-2023 Class II — Sodium Chloride 0.9 % (a) 100ML (MAGNESIUM) (b) 69.3ML, (c) 71.4ML, (d) 77.7ML, (December 27, 2022)
D-0303-2023 Class II — MEROPENEM (a) 1000MG IN NS 250ML, (b) 2GM IN NS 100ML, (c) 500mg IN NS 125ML, an (December 27, 2022)
D-0272-2023 Class II — 0.9% Sodium Chloride, used as a diluent or hydration, packaged volume of (a)100 (December 27, 2022)
D-0324-2023 Class II — VITAMIN K(PHYTONADIONE) 2.5MG(0.25ML) SYRINGE, Rx only, Sentara Home Infusion Ph (December 27, 2022)
D-0307-2023 Class II — Milrinone (a) 104MG IN 0.45% NS 130ML,(b) 108MG IN 0.45% NS 135ML, (c) 120MG IN (December 27, 2022)
D-0294-2023 Class II — GANCICLOVIR ( CYTOVENE) (a)1480MG IN NS 296ML, (b) 740 MG IN NS 336 ML, antivira (December 27, 2022)
D-0323-2023 Class II — VANCOMYCIN (a)700 MG NS 140ML, (b) 1000MG IN NS 200ML, abtibiotic, Rx only, use (December 27, 2022)
D-0302-2023 Class II — LEVOTHYROXINE 25MCG IN NS 1.25ML SYRINGE, Thyroid, Rx Only, Sentara Home Infusio (December 27, 2022)
D-0289-2023 Class II — Diphenhydramine 18mg in 3.6ML NS SYRINGE, antihistamine, Rx Only, Sentara Home I (December 27, 2022)